- Home
- CLGN vs PYN Comparison
CLGN vs PYN Comparison
Compare CLGN & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- PYN
- Stock Information
- Founded
- CLGN 2004
- PYN 2002
- Country
- CLGN Israel
- PYN United States
- Employees
- CLGN N/A
- PYN N/A
- Industry
- CLGN Industrial Specialties
- PYN Investment Managers
- Sector
- CLGN Health Care
- PYN Finance
- Exchange
- CLGN Nasdaq
- PYN Nasdaq
- Market Cap
- CLGN 37.4M
- PYN 34.0M
- IPO Year
- CLGN N/A
- PYN N/A
- Fundamental
- Price
- CLGN $2.58
- PYN $5.64
- Analyst Decision
- CLGN Strong Buy
- PYN
- Analyst Count
- CLGN 2
- PYN 0
- Target Price
- CLGN $12.50
- PYN N/A
- AVG Volume (30 Days)
- CLGN 12.3K
- PYN 19.9K
- Earning Date
- CLGN 03-26-2025
- PYN 01-01-0001
- Dividend Yield
- CLGN N/A
- PYN 5.07%
- EPS Growth
- CLGN N/A
- PYN N/A
- EPS
- CLGN N/A
- PYN N/A
- Revenue
- CLGN $515,000.00
- PYN N/A
- Revenue This Year
- CLGN $2,474.76
- PYN N/A
- Revenue Next Year
- CLGN $52.63
- PYN N/A
- P/E Ratio
- CLGN N/A
- PYN N/A
- Revenue Growth
- CLGN N/A
- PYN N/A
- 52 Week Low
- CLGN $2.54
- PYN $4.84
- 52 Week High
- CLGN $6.75
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- CLGN 26.97
- PYN 35.93
- Support Level
- CLGN $2.54
- PYN $5.60
- Resistance Level
- CLGN $3.70
- PYN $5.80
- Average True Range (ATR)
- CLGN 0.26
- PYN 0.05
- MACD
- CLGN -0.04
- PYN -0.01
- Stochastic Oscillator
- CLGN 3.45
- PYN 20.00
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.